MORF4L1 and Hypercholesterolemia: We postulated that increased LDLR H3-K36me3 could be recognized by MRG15, which in turn could recruit polypyrimidine tract-binding protein (PTB) to affect the alternative splicing of LDLR pre-mRNA in hypercholesterolemia (Figure 6).